-
Developments and Critical Issues of COVID-19 Treatment/Vaccine R&D in China
PharmaSources.com
September 21, 2020
It has been over half a year since the pandemic first outbroke in Wuhan of China. This article is to review and update what we know about treatments and vaccines development, and critical issues in the fight against the pandemic.
-
The CDE Issuing Documents to Promote the Marketing of COVID-19 Vaccines & An Overview of the Clinical Data of the Seven COVID-19 Vaccines in the World
PharmaSources/Xiaoyaowan
August 24, 2020
The CDE issued five documents including the Technical Guidelines for the Research and Development of Prophylactic Vaccines against COVID-19 (Trial) on Aug. 14.
-
Will the Bottles be Enough with the Marketing of COVID-19 Vaccine?
PharmaSources/Laoxue
June 05, 2020
The National Medical Products Administration of China issued an announcement on the chemical drug injection consistency evaluation on May 14.
-
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
B3C newswire
November 06, 2023
ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.
-
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
PharmaSources
March 07, 2023
Group reports lower revenue for 2Q on switch to immunotherapy and cell therapies from vaccines
-
New government plan to speed up elimination of cervical cancer
www.gov.cn
February 08, 2023
The central government has outlined a long-term plan to accelerate the elimination of cervical cancer by 2030 via an initiative aimed at boosting vaccination rates among girls.
-
Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply
b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
-
Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland
ExpressPharma
February 15, 2022
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials.
-
Vaccine Effectiveness Up After Three COVID-19 Vaccine Doses
drugs.com
February 14, 2022
COVID-19 vaccine effectiveness (VE) is increased after three doses but wanes with time since vaccination after receipt of two or three...
-
AstraZeneca reports 41% growth in FY 2021 total revenue
Pharmaceutical-Technology
February 11, 2022
Total revenue for the Covid-19 sector was recorded at $4.11bn in FY 2021.